Rendering

Component: (Network and Table)
Network
100280 - Disclosure - Segments and Geographic Information (Tables)
(http://www.internationalstemcell.com/20161231/taxonomy/role/DisclosureSegmentsAndGeographicInformationTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001355790 (http://www.sec.gov/CIK)
Segment Reporting [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Segment Reporting [Abstract]
 
Revenues, Expenses and Operating Income (Loss) by Market Segment

Revenues, expenses and operating income (loss) by market segment were as follows (in thousands):

 

 

 

For the Years Ended

 

 

 

December 31,

 

 

 

2016

 

 

2015

 

Revenues:

 

 

 

 

 

 

 

 

Cosmetic market

 

$

2,849

 

 

$

3,503

 

Biomedical market

 

 

4,316

 

 

 

4,048

 

Total revenues

 

 

7,165

 

 

 

7,551

 

Operating expenses:

 

 

 

 

 

 

 

 

Therapeutic market

 

 

6,154

 

 

 

6,234

 

Cosmetic market

 

 

2,797

 

 

 

3,087

 

Biomedical market

 

 

3,065

 

 

 

2,794

 

Total operating expenses

 

 

12,016

 

 

 

12,115

 

Operating income (loss):

 

 

 

 

 

 

 

 

Therapeutic market

 

 

(6,154

)

 

 

(6,234

)

Cosmetic market

 

 

52

 

 

 

416

 

Biomedical market

 

 

1,251

 

 

 

1,254

 

Total operating loss

 

$

(4,851

)

 

$

(4,564

)

 

  
Summary of Significant Revenues in Following Regions

Significant revenues in the following regions are those that are attributable to the individual country within the region to which the product was shipped (in thousands):

 

 

 

For the Years Ended

 

 

 

December 31,

 

 

 

2016

 

 

2015

 

North America

 

$

6,061

 

 

$

6,127

 

Asia

 

 

702

 

 

 

999

 

Europe

 

 

362

 

 

 

388

 

All other regions

 

 

40

 

 

 

37

 

Total

 

$

7,165

 

 

$

7,551